Pizzie Nick
Insider CIK 1742143 · AXSM Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-06-09 | 2026-06-09 | 33,000 | — | $0 | 72,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-06-09 | 2026-06-09 | 33,000 | $240.09 | $7.92M | 42,867 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-06-09 | 2026-06-09 | 33,000 | $3.50 | $115.5K | 75,867 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2026-04-21 | 2026-04-23 | 8,188 | — | $0 | 8,188 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2026-02-26 | 2026-02-27 | 18,570 | — | $0 | 18,570 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-01-22 | 2026-01-23 | 12,000 | — | $0 | 105,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-01-22 | 2026-01-23 | 12,000 | $187.92 | $2.26M | 42,588 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-01-22 | 2026-01-23 | 12,000 | $3.50 | $42.0K | 54,588 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2025-02-24 | 2025-02-25 | 9,423 | — | $0 | 9,423 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2025-02-21 | 2025-02-25 | 9,516 | — | $0 | 9,516 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2025-02-21 | 2025-02-25 | 9,423 | — | $0 | 9,423 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-02-14 | 2025-02-14 | 3,000 | $3.50 | $10.5K | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-02-14 | 2025-02-14 | 3,000 | $3.50 | $10.5K | 45,187 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-02-14 | 2025-02-14 | 3,000 | $131.07 | $393.2K | 42,187 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-02-13 | 2025-02-14 | 12,000 | $3.50 | $42.0K | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-02-13 | 2025-02-14 | 12,000 | $129.86 | $1.56M | 42,187 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-02-13 | 2025-02-14 | 12,000 | $3.50 | $42.0K | 54,187 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2024-02-27 | 2024-02-29 | 28,722 | — | $0 | 28,722 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2024-02-27 | 2024-02-29 | 15,774 | — | $0 | 15,774 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2023-03-02 | 2023-03-06 | 36,246 | — | $0 | 36,246 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2023-03-02 | 2023-03-06 | 20,554 | — | $0 | 20,554 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2022-03-04 | 2022-03-08 | 41,176 | — | $0 | 41,176 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2022-03-04 | 2022-03-08 | 77,872 | — | $0 | 77,872 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2021-11-18 | 2021-11-22 | 141 | $35.43 | $5.0K | 201 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2021-11-18 | 2021-11-22 | 145 | $34.30 | $5.0K | 145 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2021-11-18 | 2021-11-22 | 142 | $35.20 | $5.0K | 142 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2021-11-18 | 2021-11-22 | 527 | $35.50 | $18.7K | 41,789 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2021-11-12 | 2021-11-15 | 36,086 | — | $0 | 36,086 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2021-03-05 | 2021-03-09 | 36,086 | — | $0 | 36,086 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2021-03-05 | 2021-03-09 | 19,208 | — | $0 | 19,208 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2020-06-29 | 2020-06-30 | 777 | $76.64 | $59.5K | 41,217 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2020-03-17 | 2020-12-23 | 48,237 | — | $0 | 48,237 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2020-03-17 | 2020-12-23 | 14,767 | — | $0 | 14,767 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2020-03-17 | 2020-03-19 | 18,645 | — | $0 | 18,645 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2020-03-17 | 2020-03-19 | 60,880 | — | $0 | 60,880 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2019-10-10 | 2019-10-15 | 25,813 | — | $0 | 25,813 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2019-09-26 | 2019-09-30 | 2,180 | $24.80 | $54.1K | 40,440 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2019-06-11 | 2019-06-12 | 1,920 | $20.80 | $39.9K | 1,920 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2019-03-19 | 2019-03-21 | 75,102 | — | $0 | 75,102 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2019-03-19 | 2019-03-21 | 5,340 | $12.58 | $67.2K | 36,340 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2019-03-19 | 2019-03-21 | 60 | $12.69 | $761 | 60 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2018-06-19 | 2018-06-20 | 30,600 | $3.10 | $94.9K | 31,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2018-06-19 | 2018-06-20 | 400 | $3.05 | $1.2K | 400 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2018-05-16 | 2018-05-29 | 132,000 | — | $0 | 132,000 | SEC↗ |